Showing results (311-320 of 381) with videos related to
Sort By:
Pageof 39
Human Pathology|March 7, 1998
Molecular features in a biphenotypic small cell sarcoma with neuroectodermal and muscle differentiationE de Alava, M D Lozano, I Sola, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Role of leukotrienes B4 and C4 in liver allograft rejectionJ González, J A Cienfuegos, F Pardo, et al.Clinical & Experimental Metastasis|March 22, 2015
Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosisD Subirá, M Simó, J Illán, et al.Frontiers in Microbiology|January 6, 2022
Turnover of Lecanoroid Mycobionts and Their Trebouxia Photobionts Along an Elevation Gradient in Bolivia Highlights the Role of Environment in Structuring the Lichen SymbiosisIan D Medeiros, Edyta Mazur, Jolanta Miadlikowska, et al.Physics in Medicine and Biology|March 21, 2012
Evaluation of chamber response function influence on IMRT verification using 2D commercial detector arraysA Gago-Arias, L Brualla-González, D M González-Castaño, et al.Cell Death & Disease|March 4, 2011
MAGUKs, scaffolding proteins at cell junctions, are substrates of different proteases during apoptosisS Ivanova, U Gregorc, N Vidergar, et al.Journal of Medicinal Chemistry|December 19, 1998
Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523)A Rosowsky, J E Wright, C M Vaidya, et al.Neurology. Genetics|February 24, 2018
Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37AMaureen A Mealy, Tai-Seung Nam, Santiago J Pardo, et al.Physics in Medicine and Biology|September 5, 2020
Impact of charge collection efficiency and electronic noise on the performance of solid-state 3D microdetectorsJ Prieto-Pena, F Gómez, C Guardiola, et al.Liver|April 1, 1993
Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferonE de Alava, J Camps, J Pardo-Mindán, et al.Pageof 39